Clinical Trial Update: A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and tolerability of brexpiprazole in adults with Bipolar I Disorder and acute mania has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Mania

Drugs mentioned

• brexpiprazole (brexpiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Bipolar I Disorder, Acute Mania | Phase 3 | Status: COMPLETED | Results posted: 2020-08-17